Jiangsu Hengrui reported CNY2.93B in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Kangmei Pharma CNY 253.72M 16.66M Jun/2026
Sh Fosun Pharma CNY 3.07B 276.55M Sep/2026
Sh Pharmaceutical CNY 4.39B 295.76M Sep/2026
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Wuxi Apptec CNY 1.25B 263.98M Sep/2026
Zz Pientze Pharmaceu CNY 267.85M 44.71M Sep/2026